Monoclonal antibodies isolated without screening by analyzing the variable-gene repertoire of plasma cells
Isolation of antigen-specific monoclonal antibodies (mAbs) and antibody fragments relies on
high-throughput screening of immortalized B cells 1 , 2 or recombinant antibody libraries 3 , …
high-throughput screening of immortalized B cells 1 , 2 or recombinant antibody libraries 3 , …
Deep learning enables therapeutic antibody optimization in mammalian cells by deciphering high-dimensional protein sequence space
Therapeutic antibody optimization is time and resource intensive, largely because it requires
low-throughput screening (10 3 variants) of full-length IgG in mammalian cells, typically …
low-throughput screening (10 3 variants) of full-length IgG in mammalian cells, typically …
Optimization of therapeutic antibodies by predicting antigen specificity from antibody sequence via deep learning
The optimization of therapeutic antibodies is time-intensive and resource-demanding, largely
because of the low-throughput screening of full-length antibodies (approximately 1 × 10 3 …
because of the low-throughput screening of full-length antibodies (approximately 1 × 10 3 …
[HTML][HTML] Exploiting lymphatic transport and complement activation in nanoparticle vaccines
Antigen targeting 1 , 2 , 3 , 4 , 5 and adjuvancy schemes 6 , 7 that respectively facilitate
delivery of antigen to dendritic cells and elicit their activation have been explored in vaccine …
delivery of antigen to dendritic cells and elicit their activation have been explored in vaccine …
NTIRE 2022 challenge on night photography rendering
This paper reviews the NTIRE 2022 challenge on night photography rendering. The
challenge solicited solutions that processed RAW camera images captured in night scenes to …
challenge solicited solutions that processed RAW camera images captured in night scenes to …
In vivo targeting of dendritic cells in lymph nodes with poly (propylene sulfide) nanoparticles
ST Reddy, A Rehor, HG Schmoekel, JA Hubbell… - Journal of Controlled …, 2006 - Elsevier
Delivery of biodegradable nanoparticles to antigen-presenting cells (APCs), specifically
dendritic cells (DCs), has potential for immunotherapy. This study investigates the delivery of 20, …
dendritic cells (DCs), has potential for immunotherapy. This study investigates the delivery of 20, …
Targeting dendritic cells with biomaterials: developing the next generation of vaccines
Current vaccine and immunotherapy technology faces ongoing challenges in both efficacy
and practicality: many chronic diseases cannot yet be addressed by vaccination, and several …
and practicality: many chronic diseases cannot yet be addressed by vaccination, and several …
[HTML][HTML] Epidemiology and risk factors of chronic kidney disease in India–results from the SEEK (Screening and Early Evaluation of Kidney Disease) study
…, YMK Farag, BV Mittal, KK Subramanian, SRK Reddy… - BMC nephrology, 2013 - Springer
Background There is a rising incidence of chronic kidney disease that is likely to pose major
problems for both healthcare and the economy in future years. In India, it has been recently …
problems for both healthcare and the economy in future years. In India, it has been recently …
Trastuzumab emtansine (T-DM1) renders HER2+ breast cancer highly susceptible to CTLA-4/PD-1 blockade
…, M von Bergwelt-Baildon, H Kreipe, S Reddy… - Science translational …, 2015 - science.org
Targeted drug delivery with antibody-drug conjugates such as the HER2-directed ado-trastuzumab
emtansine (T-DM1) has emerged as a powerful strategy for cancer therapy. We show …
emtansine (T-DM1) has emerged as a powerful strategy for cancer therapy. We show …
[PDF][PDF] Deep mutational learning predicts ACE2 binding and antibody escape to combinatorial mutations in the SARS-CoV-2 receptor-binding domain
The continual evolution of SARS-CoV-2 and the emergence of variants that show resistance
to vaccines and neutralizing antibodies threaten to prolong the COVID-19 pandemic. …
to vaccines and neutralizing antibodies threaten to prolong the COVID-19 pandemic. …
